Clinical Trial Update: Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing IMRT or IMPT plus CIRT for nasopharyngeal carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Lin Kong, MD | Conditions: Nasopharyngeal Cancinoma (NPC) | Phase 3 | Status: RECRUITING